Revolution Medicines, Inc. RVMD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$1.13B-88.5% | -$600.09M-37.5% | -$436.37M-75.5% | -$248.71M-32.9% | ||
| $7.78M+20.2% | $6.48M+28.2% | $5.05M+26.9% | $3.98M+29.1% | ||
| $118.39M+49.5% | $79.2M+28.2% | $61.77M+98.0% | $31.2M+50.5% | ||
| -$897.74M-61.0% | -$557.44M-59.0% | -$350.57M-56.2% | -$224.4M-52.5% | ||
| $15.99M+55.1% | $10.31M+33.4% | $7.73M-28.5% | $10.82M+65.7% | ||
| $118.06M— | —— | -$342.6M-1,321% | -$24.12M+84.0% | ||
| $623.12M-35.1% | $959.41M-21.9% | $1.23B+308% | $301.43M+2.5% | ||
| —— | —— | —— | —— | ||
| -$913.73M-60.9% | -$567.74M-58.5% | -$358.3M-52.3% | -$235.22M-53.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Revolution Medicines, Inc. generate?
- Revolution Medicines, Inc. (RVMD) generated -$1.1B in operating cash flow over the trailing twelve months.
- What is Revolution Medicines, Inc.'s free cash flow?
- After $14.3M of capital expenditures, Revolution Medicines, Inc.'s free cash flow was -$1.1B over the trailing twelve months, down 78.1% year over year.
- Where does Revolution Medicines, Inc.'s cash flow data come from?
- Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.